DK0754176T3 - Hidtil ukendte carbamater og urinstoffer som modifikatorer for multidrugsresistens - Google Patents
Hidtil ukendte carbamater og urinstoffer som modifikatorer for multidrugsresistensInfo
- Publication number
- DK0754176T3 DK0754176T3 DK95914866T DK95914866T DK0754176T3 DK 0754176 T3 DK0754176 T3 DK 0754176T3 DK 95914866 T DK95914866 T DK 95914866T DK 95914866 T DK95914866 T DK 95914866T DK 0754176 T3 DK0754176 T3 DK 0754176T3
- Authority
- DK
- Denmark
- Prior art keywords
- ureas
- modifiers
- multidrug resistance
- compounds
- newly known
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21812094A | 1994-03-25 | 1994-03-25 | |
US08/377,283 US5744485A (en) | 1994-03-25 | 1995-01-23 | Carbamates and ureas as modifiers of multi-drug resistance |
PCT/US1995/003716 WO1995026337A1 (en) | 1994-03-25 | 1995-03-23 | Novel carbamates and ureas as modifiers of multi-drug resistance |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0754176T3 true DK0754176T3 (da) | 2002-04-02 |
Family
ID=26912595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95914866T DK0754176T3 (da) | 1994-03-25 | 1995-03-23 | Hidtil ukendte carbamater og urinstoffer som modifikatorer for multidrugsresistens |
Country Status (13)
Country | Link |
---|---|
US (1) | US5744485A (da) |
EP (2) | EP1138673B1 (da) |
JP (1) | JP4421680B2 (da) |
AT (2) | ATE403430T1 (da) |
AU (1) | AU704475B2 (da) |
CA (1) | CA2186380C (da) |
DE (2) | DE69535805D1 (da) |
DK (1) | DK0754176T3 (da) |
ES (2) | ES2169127T3 (da) |
HK (1) | HK1013993A1 (da) |
NZ (1) | NZ283599A (da) |
PT (1) | PT754176E (da) |
WO (1) | WO1995026337A1 (da) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5798355A (en) * | 1995-06-07 | 1998-08-25 | Gpi Nil Holdings, Inc. | Inhibitors of rotamase enzyme activity |
US5846981A (en) * | 1993-05-28 | 1998-12-08 | Gpi Nil Holdings Inc. | Inhibitors of rotamase enzyme activity |
US5744485A (en) * | 1994-03-25 | 1998-04-28 | Vertex Pharmaceuticals Incorporated | Carbamates and ureas as modifiers of multi-drug resistance |
US20030036654A1 (en) * | 1994-08-18 | 2003-02-20 | Holt Dennis A. | Synthetic multimerizing agents |
US6133456A (en) * | 1994-08-18 | 2000-10-17 | Ariad Gene Therapeutics, Inc. | Synthetic multimerizing agents |
US6150527A (en) * | 1994-08-18 | 2000-11-21 | Ariad Pharmaceuticals, Inc. | Synthetic multimerizing agents |
US5543423A (en) * | 1994-11-16 | 1996-08-06 | Vertex Pharmaceuticals, Incorporated | Amino acid derivatives with improved multi-drug resistance activity |
IL115685A (en) * | 1994-11-16 | 2000-08-31 | Vertex Pharma | Amino acid derivatives pharmaceutical compositions containing the same and processes for the preparation thereof |
US5859031A (en) * | 1995-06-07 | 1999-01-12 | Gpi Nil Holdings, Inc. | Small molecule inhibitors of rotamase enzyme activity |
US5696135A (en) * | 1995-06-07 | 1997-12-09 | Gpi Nil Holdings, Inc. | Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth |
US5801197A (en) * | 1995-10-31 | 1998-09-01 | Gpi Nil Holdings, Inc. | Rotamase enzyme activity inhibitors |
AU1597197A (en) * | 1996-02-01 | 1997-08-22 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Thienoquinolines |
US6218424B1 (en) | 1996-09-25 | 2001-04-17 | Gpi Nil Holdings, Inc. | Heterocyclic ketone and thioester compounds and uses |
US5801187A (en) * | 1996-09-25 | 1998-09-01 | Gpi-Nil Holdings, Inc. | Heterocyclic esters and amides |
US5786378A (en) * | 1996-09-25 | 1998-07-28 | Gpi Nil Holdings, Inc. | Heterocyclic thioesters |
US5780484A (en) * | 1996-11-13 | 1998-07-14 | Vertex Pharmaceuticals Incorporated | Methods for stimulating neurite growth with piperidine compounds |
US5935989A (en) * | 1996-12-31 | 1999-08-10 | Gpi Nil Holdings Inc. | N-linked ureas and carbamates of heterocyclic thioesters |
NZ336386A (en) * | 1996-12-31 | 2001-09-28 | Guilford Pharm Inc | An urea or carbamate derivative of heterocyclic thioester useful for effecting neuronal activity |
US6242468B1 (en) * | 1997-02-27 | 2001-06-05 | Jia-He Li | Carbamate and urea compositions and neurotrophic uses |
ZA98825B (en) * | 1997-02-27 | 1998-10-19 | Guilford Pharm Inc | Method of using neurotrophic carbamates and ureas |
US5846979A (en) | 1997-02-28 | 1998-12-08 | Gpi Nil Holdings, Inc. | N-oxides of heterocyclic esters, amides, thioesters, and ketones |
IT1291607B1 (it) * | 1997-04-18 | 1999-01-11 | Fabbrica Italiana Sintetici Spa | Processo di sintesi di 1,7-diaril oppure eteroaril eptan-4-oli e nuovi intermedi di sintesi |
US5945441A (en) | 1997-06-04 | 1999-08-31 | Gpi Nil Holdings, Inc. | Pyrrolidine carboxylate hair revitalizing agents |
US6268384B1 (en) * | 1997-08-29 | 2001-07-31 | Vertex Pharmaceuticals Incorporated | Compounds possessing neuronal activity |
ID23675A (id) * | 1997-08-29 | 2000-05-11 | Vertex Pharma | Senyawa-senyawa yang mempunyai aktivitas neuronal |
KR20010042471A (ko) * | 1998-04-08 | 2001-05-25 | 피터 지. 스트링거 | Mrp1의 억제 방법 |
BR9909497A (pt) | 1998-04-08 | 2000-12-12 | Lilly Co Eli | Métodos para inibição da mrp1 |
US6410041B1 (en) | 1998-04-28 | 2002-06-25 | Trustees Of Tufts College | Culturing cells in presence of amphipathic weak bases and/or cations and multiple drug resistance inhibitor containing reserpine |
JP2002516904A (ja) | 1998-06-03 | 2002-06-11 | ジーピーアイ ニル ホールディングス インコーポレイテッド | N−複素環式カルボン酸またはカルボン酸等配電子体のn−結合スルホンアミド |
US6331537B1 (en) | 1998-06-03 | 2001-12-18 | Gpi Nil Holdings, Inc. | Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds |
IL140039A0 (en) * | 1998-06-03 | 2002-02-10 | Guilford Pharm Inc | Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres |
US6333340B1 (en) | 1998-08-14 | 2001-12-25 | Gpi Nil Holdings, Inc. | Small molecule sulfonamides for vision and memory disorders |
US6395758B1 (en) | 1998-08-14 | 2002-05-28 | Gpi Nil Holdings, Inc. | Small molecule carbamates or ureas for vision and memory disorders |
US6335348B1 (en) | 1998-08-14 | 2002-01-01 | Gpi Nil Holdings, Inc. | Nitrogen-containing linear and azepinyl/ compositions and uses for vision and memory disorders |
US6384056B1 (en) | 1998-08-14 | 2002-05-07 | Gpi Nil Holdings, Inc. | Heterocyclic thioesters or ketones for vision and memory disorders |
US6376517B1 (en) | 1998-08-14 | 2002-04-23 | Gpi Nil Holdings, Inc. | Pipecolic acid derivatives for vision and memory disorders |
US6218423B1 (en) | 1998-08-14 | 2001-04-17 | Gpi Nil Holdings, Inc. | Pyrrolidine derivatives for vision and memory disorders |
US6399648B1 (en) | 1998-08-14 | 2002-06-04 | Gpi Nil Holdings, Inc. | N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
US7338976B1 (en) | 1998-08-14 | 2008-03-04 | Gpi Nil Holdings, Inc. | Heterocyclic esters or amides for vision and memory disorders |
US6337340B1 (en) | 1998-08-14 | 2002-01-08 | Gpi Nil Holdings, Inc. | Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders |
US6506788B1 (en) | 1998-08-14 | 2003-01-14 | Gpi Nil Holdings, Inc. | N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders |
US6339101B1 (en) | 1998-08-14 | 2002-01-15 | Gpi Nil Holdings, Inc. | N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
US6462072B1 (en) | 1998-09-21 | 2002-10-08 | Gpi Nil Holdings, Inc. | Cyclic ester or amide derivatives |
US6307049B1 (en) | 1998-09-30 | 2001-10-23 | The Procter & Gamble Co. | Heterocyclic 2-substituted ketoamides |
US6300341B1 (en) | 1998-09-30 | 2001-10-09 | The Procter & Gamble Co. | 2-substituted heterocyclic sulfonamides |
WO2001008685A1 (en) * | 1999-07-30 | 2001-02-08 | Vertex Pharmaceuticals Incorporated | Acyclic and cyclic amine derivatives |
WO2001010838A1 (en) * | 1999-08-05 | 2001-02-15 | The Procter & Gamble Company | Multivalent compounds |
WO2001010837A1 (en) * | 1999-08-05 | 2001-02-15 | The Procter & Gamble Company | Multivalent sulfonamides |
US6417189B1 (en) | 1999-11-12 | 2002-07-09 | Gpi Nil Holdings, Inc. | AZA compounds, pharmaceutical compositions and methods of use |
US7253169B2 (en) | 1999-11-12 | 2007-08-07 | Gliamed, Inc. | Aza compounds, pharmaceutical compositions and methods of use |
CA2393466C (en) | 1999-12-21 | 2010-01-19 | Gpi Nil Holdings, Inc. | Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same |
CZ20031262A3 (en) * | 2000-10-16 | 2004-03-17 | Neopharm, Inc. | Liposomal formulation of mitoxantrone |
US6693099B2 (en) | 2000-10-17 | 2004-02-17 | The Procter & Gamble Company | Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
US6376514B1 (en) * | 2000-10-17 | 2002-04-23 | The Procter & Gamble Co. | Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof |
CA2449019A1 (en) * | 2001-05-29 | 2002-12-05 | Guilford Pharmaceuticals Inc. | Method for treating nerve injury caused by surgery |
WO2003041128A2 (en) * | 2001-11-07 | 2003-05-15 | Pharmacia Corporation | Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells |
WO2003062773A1 (en) * | 2002-01-24 | 2003-07-31 | Pei Electronics, Inc. | Compact integrated infrared scene projector |
EP1402888A1 (en) * | 2002-09-18 | 2004-03-31 | Jerini AG | The use of substituted carbocyclic compounds as rotamases inhibitors |
RU2408581C2 (ru) * | 2005-02-17 | 2011-01-10 | Астеллас Фарма Инк. | Пиридильное неароматическое азотсодержащее гетероцикло-1-карбоксилатное производное |
CN102655865A (zh) | 2009-09-11 | 2012-09-05 | 沃泰克斯药物股份有限公司 | N-苄基-3-(4-氯苯基)-2-[甲基-[2-氧代-2-(3,4,5-三甲氧基苯基)乙酰基]氨基]-n-[3-(4-吡啶基)-1-[2-(4-吡啶基)乙基]丙酰胺的组合物及其用途 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT71654B (en) * | 1979-08-15 | 1982-01-22 | Merck & Co Inc | Process for preparing allylsulfoxide enzyme inhibitor |
NZ228855A (en) * | 1988-04-25 | 1992-08-26 | Hoffmann La Roche | Tyrosine analogues and peptides containing them especially cholecystokinin (cck) analogues |
HUT58764A (en) * | 1988-07-08 | 1992-03-30 | Smithkline Beckman Corp | Process for producing peptides, pharmaceutical compositions containing them and amino-acid intermediates |
ATE118216T1 (de) * | 1989-04-20 | 1995-02-15 | Zambon Spa | Dopamin-medikament-vorstufe. |
CA2037153A1 (en) * | 1990-03-09 | 1991-09-10 | Leo Alig | Acetic acid derivatives |
EP0493683A1 (en) * | 1990-12-20 | 1992-07-08 | American Cyanamid Company | Fungicidal amino acid amides |
DE4102042A1 (de) * | 1991-01-24 | 1992-07-30 | Bayer Ag | Substituierte aminosaeureamid-derivate deren herstellung und verwendung als fungizide |
DK0584223T3 (da) * | 1991-05-09 | 2000-03-13 | Vertex Pharma | Hidtil ukendte immunsuppressive forbindelser |
FR2678938B1 (fr) * | 1991-07-10 | 1993-10-08 | Rhone Poulenc Rorer Sa | Derives de pyrrolidine, leur preparation et les medicaments les contenant. |
KR930702383A (ko) * | 1991-08-26 | 1993-09-08 | 시게루 미즈노 | 면역조절성을 가지는 슈도펜타펩티드 |
JPH05294915A (ja) * | 1992-04-21 | 1993-11-09 | Yamanouchi Pharmaceut Co Ltd | タキキニン拮抗剤 |
US5284840A (en) * | 1992-06-12 | 1994-02-08 | Merck & Co., Inc. | Alkylidene macrolides having immunosuppressive activity |
NZ314207A (en) * | 1992-09-28 | 2000-12-22 | Vertex Pharma | 1-(2-Oxoacetyl)-piperidine-2-carboxylic acid derivatives as multi drug resistant cancer cell sensitizers |
US5744485A (en) * | 1994-03-25 | 1998-04-28 | Vertex Pharmaceuticals Incorporated | Carbamates and ureas as modifiers of multi-drug resistance |
US5543423A (en) * | 1994-11-16 | 1996-08-06 | Vertex Pharmaceuticals, Incorporated | Amino acid derivatives with improved multi-drug resistance activity |
-
1995
- 1995-01-23 US US08/377,283 patent/US5744485A/en not_active Expired - Lifetime
- 1995-03-23 JP JP52523595A patent/JP4421680B2/ja not_active Expired - Fee Related
- 1995-03-23 CA CA002186380A patent/CA2186380C/en not_active Expired - Fee Related
- 1995-03-23 AT AT01111169T patent/ATE403430T1/de not_active IP Right Cessation
- 1995-03-23 AT AT95914866T patent/ATE210119T1/de not_active IP Right Cessation
- 1995-03-23 PT PT95914866T patent/PT754176E/pt unknown
- 1995-03-23 AU AU21943/95A patent/AU704475B2/en not_active Ceased
- 1995-03-23 EP EP01111169A patent/EP1138673B1/en not_active Expired - Lifetime
- 1995-03-23 ES ES95914866T patent/ES2169127T3/es not_active Expired - Lifetime
- 1995-03-23 DE DE69535805T patent/DE69535805D1/de not_active Expired - Lifetime
- 1995-03-23 DE DE69524400T patent/DE69524400T2/de not_active Expired - Lifetime
- 1995-03-23 ES ES01111169T patent/ES2311491T3/es not_active Expired - Lifetime
- 1995-03-23 WO PCT/US1995/003716 patent/WO1995026337A1/en active IP Right Grant
- 1995-03-23 EP EP95914866A patent/EP0754176B1/en not_active Expired - Lifetime
- 1995-03-23 NZ NZ283599A patent/NZ283599A/en not_active IP Right Cessation
- 1995-03-23 DK DK95914866T patent/DK0754176T3/da active
-
1998
- 1998-12-23 HK HK98115243A patent/HK1013993A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MX9604305A (es) | 1997-12-31 |
EP0754176B1 (en) | 2001-12-05 |
AU2194395A (en) | 1995-10-17 |
US5744485A (en) | 1998-04-28 |
HK1013993A1 (en) | 1999-09-17 |
DE69524400D1 (de) | 2002-01-17 |
JPH09510974A (ja) | 1997-11-04 |
JP4421680B2 (ja) | 2010-02-24 |
ATE210119T1 (de) | 2001-12-15 |
ES2311491T3 (es) | 2009-02-16 |
EP1138673A3 (en) | 2001-10-17 |
AU704475B2 (en) | 1999-04-22 |
WO1995026337A1 (en) | 1995-10-05 |
ES2169127T3 (es) | 2002-07-01 |
CA2186380A1 (en) | 1995-10-05 |
EP1138673A2 (en) | 2001-10-04 |
EP0754176A1 (en) | 1997-01-22 |
NZ283599A (en) | 1998-06-26 |
DE69535805D1 (de) | 2008-09-18 |
CA2186380C (en) | 2008-12-02 |
EP1138673B1 (en) | 2008-08-06 |
ATE403430T1 (de) | 2008-08-15 |
PT754176E (pt) | 2002-05-31 |
DE69524400T2 (de) | 2002-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0754176T3 (da) | Hidtil ukendte carbamater og urinstoffer som modifikatorer for multidrugsresistens | |
IS4073A (is) | Nýtt fjölvirknislyf gegn aukningu mótstöðu | |
DE69725293D1 (de) | N-(2 oxoacetyl oder sulphonyl)-pyrrolidine/piperidine-2-carbonsäurederivate mit verbesserter multi-drug resistenz aktivität | |
NO20003230L (no) | Inhibering av RAF-kinase ved anvendelse av symmetrisk og usymmetrisk substituerte difenylureaforbindelser | |
DE69716810T2 (de) | 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one | |
DK0839143T3 (da) | Tetralinforbindelser med MDR-aktivitet | |
DK1032556T3 (da) | Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder | |
NO975028D0 (no) | Piperazinoderivater som neurokininantagonister |